Alternatives to Surf Therapeutics

Medical technology company developing bio-integrative, metal-free orthopedic fixation implants for natural bone healing.

Biotech company developing targeted regenerative therapeutics using a proprietary protein engineering platform for tissue repair.

Developing implantable neuroimmune modulation therapies to treat chronic autoimmune diseases like rheumatoid arthritis.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionizing genomic analysis with innovative sequencing technology.

Develops and distributes bioreactor technology for stem cell cultivation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.